144 related articles for article (PubMed ID: 27546834)
21. Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability.
Perrey DA; Decker AM; Zhang Y
ACS Chem Neurosci; 2018 Mar; 9(3):587-602. PubMed ID: 29129052
[TBL] [Abstract][Full Text] [Related]
22. Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2.
Sifferlen T; Boller A; Chardonneau A; Cottreel E; Gatfield J; Treiber A; Roch C; Jenck F; Aissaoui H; Williams JT; Brotschi C; Heidmann B; Siegrist R; Boss C
Bioorg Med Chem Lett; 2015 May; 25(9):1884-91. PubMed ID: 25838147
[TBL] [Abstract][Full Text] [Related]
23. Orexin research: patent news from 2016.
Boss C; Roch C
Expert Opin Ther Pat; 2017 Oct; 27(10):1123-1133. PubMed ID: 28631980
[TBL] [Abstract][Full Text] [Related]
24. Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity.
Turku A; Rinne MK; Boije Af Gennäs G; Xhaard H; Lindholm D; Kukkonen JP
PLoS One; 2017; 12(6):e0178526. PubMed ID: 28575023
[TBL] [Abstract][Full Text] [Related]
25. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation.
Hong C; Byrne NJ; Zamlynny B; Tummala S; Xiao L; Shipman JM; Partridge AT; Minnick C; Breslin MJ; Rudd MT; Stachel SJ; Rada VL; Kern JC; Armacost KA; Hollingsworth SA; O'Brien JA; Hall DL; McDonald TP; Strickland C; Brooun A; Soisson SM; Hollenstein K
Nat Commun; 2021 Feb; 12(1):815. PubMed ID: 33547286
[TBL] [Abstract][Full Text] [Related]
26. Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology.
Stump CA; Cooke AJ; Bruno J; Cabalu TD; Gotter AL; Harell CM; Kuduk SD; McDonald TP; O'Brien J; Renger JJ; Williams PD; Winrow CJ; Coleman PJ
Bioorg Med Chem Lett; 2016 Dec; 26(23):5809-5814. PubMed ID: 27818110
[TBL] [Abstract][Full Text] [Related]
27. Role of orexin-2 and CB1 receptors within the periaqueductal gray matter in lateral hypothalamic-induced antinociception in rats.
Esmaeili MH; Reisi Z; Ezzatpanah S; Haghparast A
Behav Pharmacol; 2017 Feb; 28(1):83-89. PubMed ID: 27906750
[TBL] [Abstract][Full Text] [Related]
28. Involvement of orexin-1 and orexin-2 receptors within the dentate gyrus of the hippocampus in the acquisition, expression and extinction of lateral hypothalamic-induced conditioned place preference in the rats.
Parsania S; Moradi M; Fatahi Z; Haghparast A
Brain Res; 2016 May; 1639():149-60. PubMed ID: 26987804
[TBL] [Abstract][Full Text] [Related]
29. Selective orexin receptor antagonists.
Lebold TP; Bonaventure P; Shireman BT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4761-9. PubMed ID: 23891187
[TBL] [Abstract][Full Text] [Related]
30. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats.
Xue Y; Yang YT; Liu HY; Chen WF; Chen AQ; Sheng Q; Chen XY; Wang Y; Chen H; Liu HX; Pang YY; Chen L
Eur J Neurosci; 2016 Sep; 44(5):2247-57. PubMed ID: 27336845
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26.
Rinne MK; Leino TO; Turku A; Turunen PM; Steynen Y; Xhaard H; Wallén EAA; Kukkonen JP
Eur J Pharmacol; 2018 Oct; 837():137-144. PubMed ID: 30194937
[TBL] [Abstract][Full Text] [Related]
32. Investigation of New Orexin 2 Receptor Modulators Using
Janockova J; Dolezal R; Nepovimova E; Kobrlova T; Benkova M; Kuca K; Konecny J; Mezeiova E; Melikova M; Hepnarova V; Ring A; Soukup O; Korabecny J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30423961
[TBL] [Abstract][Full Text] [Related]
33. Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.
Nicole P; Couvineau P; Jamin N; Voisin T; Couvineau A
Br J Pharmacol; 2015 Nov; 172(21):5211-23. PubMed ID: 26282891
[TBL] [Abstract][Full Text] [Related]
34. Role of orexin receptors in the ventral tegmental area on acquisition and expression of morphine-induced conditioned place preference in the rats.
Farahimanesh S; Zarrabian S; Haghparast A
Neuropeptides; 2017 Dec; 66():45-51. PubMed ID: 28890208
[TBL] [Abstract][Full Text] [Related]
35. Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based Design.
Lessel U; Ferrara M; Heine N; Marelli C; Carrettoni L; Pfau R; Schmidt E; Riether D
J Chem Inf Model; 2021 Dec; 61(12):5893-5905. PubMed ID: 34817173
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.
Yin J; Mobarec JC; Kolb P; Rosenbaum DM
Nature; 2015 Mar; 519(7542):247-50. PubMed ID: 25533960
[TBL] [Abstract][Full Text] [Related]
37. Essential structure of orexin 1 receptor antagonist YNT-707, part III: Role of the 14-hydroxy and the 3-methoxy groups in antagonistic activity toward the orexin 1 receptor in YNT-707 derivatives lacking the 4,5-epoxy ring.
Yamamoto N; Ohrui S; Okada T; Saitoh T; Kutsumura N; Nagumo Y; Irukayama-Tomobe Y; Ogawa Y; Ishikawa Y; Watanabe Y; Hayakawa D; Gouda H; Yanagisawa M; Nagase H
Bioorg Med Chem; 2019 Apr; 27(8):1747-1758. PubMed ID: 30871861
[TBL] [Abstract][Full Text] [Related]
38. The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders.
Boss C; Gatfield J; Brotschi C; Heidmann B; Sifferlen T; von Raumer M; Schmidt G; Williams JT; Treiber A; Roch C
ChemMedChem; 2020 Dec; 15(23):2286-2305. PubMed ID: 32937014
[TBL] [Abstract][Full Text] [Related]
39. Essential structure of orexin 1 receptor antagonist YNT-707, Part I: Role of the 4,5-epoxy ring for binding with orexin 1 receptor.
Yamamoto N; Ohrui S; Okada T; Yata M; Saitoh T; Kutsumura N; Nagumo Y; Irukayama-Tomobe Y; Ogawa Y; Ishikawa Y; Watanabe Y; Hayakawa D; Gouda H; Yanagisawa M; Nagase H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4176-4179. PubMed ID: 28739044
[TBL] [Abstract][Full Text] [Related]
40. Essential structure of orexin 1 receptor antagonist YNT-707, Part IV: The role of D-ring in 4,5-epoxymorphinan on the orexin 1 receptor antagonistic activity.
Saitoh T; Seki K; Nakajima R; Yamamoto N; Kutsumura N; Nagumo Y; Irukayama-Tomobe Y; Ogawa Y; Ishikawa Y; Tanimura R; Yanagisawa M; Nagase H
Bioorg Med Chem Lett; 2019 Sep; 29(18):2655-2658. PubMed ID: 31375290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
